Control of Fluoroquinolone Resistance through Successful Regulation, Australia

Cheng, Allen C.; Turnidge, John; Collignon, Peter; Looke, David; Barton, Mary; Gottlieb, Thomas

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Control of Fluoroquinolone Resistance through Successful Regulation, Australia

Published Date:

Sep 2012

Source:

Emerg Infect Dis. 18(9):1453-1460.

[PDF - 229.98 KB]

Details:

Personal Authors:

Cheng, Allen C. ; Turnidge, John ; Collignon, Peter ; Looke, David ; Barton, Mary ; ... More ▼

Keywords:

[+]

Description:

Fluoroquinolone antimicrobial drugs are highly bioavailable, broad-spectrum agents with activity against gram-negative pathogens, especially those resistant to other classes of antimicrobial drugs. Australia has restricted the use of quinolones in humans through its national pharmaceutical subsidy scheme; and, through regulation, has not permitted the use of quinolones in food-producing animals. As a consequence, resistance to fluoroquinolones in the community has been slow to emerge and has remained at low levels in key pathogens, such as Escherichia coli. In contrast to policies in most other countries, this policy has successfully preserved the utility of this class of antimicrobial drugs for treatment of most infections.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Supporting Files:

11-1515-F1.gif	image/gif
11-1515-F1.jpg	image/jpeg
11-1515-F2.gif	image/gif
11-1515-F2.jpg	image/jpeg
11-1515.nxml	text/plain
license.txt	text/plain

No Related Documents.

You May Also Like:

Emerging mechanisms of fluoroquinolone resistance.

Personal Author:

Hooper, D. C.

Published:

2001 Mar-Apr

Source:

Emerg Infect Dis. 7(2):337-341.

Description:

Broad use of fluoroquinolones has been followed by emergence of resistance, which has been due mainly to chromosomal mutations in genes encoding the subunits of the drugs' target enzymes, DNA gyrase and topoisomerase IV, and in genes that affect the ...

File Type:

[PDF - 55.47 KB]
Fluoroquinolone Resistance in Campylobacter Absent from Isolates, Australia

Personal Author:

Unicomb, Leanne; Ferguson, John; Riley, Thomas V; Collignon, Peter;

Published:

Nov 2003

Source:

Emerg Infect Dis. 9(11):1482-1483.

Description:

Fluoroquinolone resistance was detected in 12 of 370 Australian human Campylobacter isolates; 10 of these were travel-associated, and for 2 isolates travel status was unknown. No resistance was found in isolates known to be locally acquired. In Austr...

File Type:

[PDF - 185.10 KB]
Factors Influencing Fluoroquinolone Resistance

Personal Author:

Sahm, Daniel F.; Thornsberry, Clyde; Jones, Mark E.; Karlowsky, James A.;

Published:

Dec 2003

Source:

Emerg Infect Dis. 9(12):1651-1654.

File Type:

[PDF - 162.56 KB]
Fluoroquinolone resistance in Neisseria gonorrhoeae.

Personal Author:

Knapp, Joan S.; Fox, Kimberley K.; Trees, David L.; Whittington, William L.;

Published:

1997 Jan-Mar

Source:

Emerg Infect Dis. 3(1):33-39.

Description:

Fluoroquinolones and broad-spectrum cephalosporins are the most effective antimicrobial agents for the treatment of gonorrhea. However, clinically significant resistance to fluoroquinolones has emerged in Neisseria gonorrhoeae. Fluoroquinolone-resist...

File Type:

[PDF - 43.30 KB]
New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations

Personal Author:

Malik, Seidu; Willby, Melisa; Sikes, David; Tsodikov, Oleg V.; Posey, James E.;

Published:

Jun 28 2012

Source:

PLoS One. 2012; 7(6).

Description:

Fluoroquinolone antibiotics are among the most potent second-line drugs used for treatment of multidrug-resistant tuberculosis (MDR TB), and resistance to this class of antibiotics is one criterion for defining extensively drug resistant tuberculosis...

File Type:

[PDF - 407.03 KB]